Concepedia

Complete tumor response of a locally advanced lung large-cell neuroendocrine carcinoma after palliative thoracic radiotherapy and immunotherapy with nivolumab

Charlotte Mauclet, Fabrice Duplaquet, Lionel Pirard, Benoı̂t Rondelet, Michaël Dupont, Claudia Pop-Stanciu, Thierry Vander Borght, Myriam Remmelink, Nicky D’Haene, Suzan Lambin,

Lung Cancer · 2018 · 43 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text

, , +17

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst, Dong‐Wan Kim, Enriqueta Felip et al. · The Lancet · 2015 · 6.5K citations

, , +14

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text

, , +15

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith et al. · New England Journal of Medicine · 2018 · 2.1K citations · Full text

, , +17

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets

Natasha Rekhtman, M. Catherine Pietanza, Matthew D. Hellmann et al. · Clinical Cancer Research · 2016 · 472 citations · Full text

, , +17